Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.55 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | CRHBP | P24387 | 1/20 | 0.47 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9465077 | 0.85 | POLB (0.57) | TAS1R3TAS1R1NPSR1LMNAALDH1A1 | |
| SCHEMBL9465072 | 0.85 | POLB (0.57) | TAS1R3TAS1R1NPSR1LMNAALDH1A1 | |
| SCHEMBL31389126 | 0.85 | TAS1R3 (0.79) | TAS1R3TAS1R1NPSR1LMNAALDH1A1 | |
| SCHEMBL810644 | 0.84 | TAS1R3 (0.69) | TAS1R3TAS1R1NPSR1ALDH1A1MAPT | |
| SCHEMBL31389160 | 0.82 | NPSR1 (0.60) | TAS1R3TAS1R1NPSR1LMNAALDH1A1 | |
| SCHEMBL31389153 | 0.80 | TAS1R3 (0.61) | TAS1R3TAS1R1NPSR1ALDH1A1MAPT | |
| SCHEMBL20299847 | 0.79 | NPSR1 (0.54) | TAS1R3TAS1R1NPSR1LMNAHTT | |
| SCHEMBL20299850 | 0.79 | NPSR1 (0.54) | TAS1R3TAS1R1NPSR1LMNAHTT | |
| SCHEMBL25496389 | 0.79 | LMNA (0.55) | TAS1R3TAS1R1NPSR1LMNAALDH1A1 | |
| SCHEMBL17822209 | 0.78 | TAS1R3 (0.69) | TAS1R3TAS1R1LMNAALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7902281-B2 | Thermoplastic resin composition and molded article thereof | MITSUI CHEMICALS, INC. (JP) | 2011-03-08 | — | — | US | disclosed |
| US-20090186992-A1 | THERMOPLASTIC RESIN COMPOSITION AND MOLDED ARTICLE THEREOF | MITSUI CHEMICALS, INC (JP) | 2009-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090186992-A1 | THERMOPLASTIC RESIN COMPOSITION AND MOLDED ARTICLE THEREOF | TRIM59, TRIM4, MAP1LC3C | TAS1R3 1722/4885TAS1R1 1732/4885NPSR1 3018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.